C

Cellectar Biosciences
D

CLRB

0.25930
USD
0.02
(9.46%)
مفتوح الان
حجم التداول
21,546
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
10,701,267
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: Cellectar Biosciences

القطاع: Healthcare
الصناعة: Biotechnology
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. Its PDC therapeutic, iopofosine is a small-molecule PDC designed to provide targeted delivery of iodine-131 directly to cancer cells, while limiting exposure to healthy cells.